Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist
PR Wade(Johnson & Johnson (United States)), PJ Hornby(Johnson & Johnson (United States)), Velga A. Kenigs(Johnson & Johnson (United States)), Sandra McKenney(Johnson & Johnson (United States)), Kristen Chevalier(Johnson & Johnson (United States)), JM Palmer(Johnson & Johnson (United States)), JR Mabus(Johnson & Johnson (United States)), ES Kimball(Johnson & Johnson (United States)), HJ Breslin(Johnson & Johnson (United States)), NH Wallace(Johnson & Johnson (United States)), Wei He(Hebei Medical University), CR Schneider(Johnson & Johnson (United States)), B W Moore(Johnson & Johnson (United States)), P. R. Saunders(Johnson & Johnson (United States))
Cited by 121
Related Papers
<i>C</i>-Glycosidation Technology With Free Radical Reactions
|Synlett|1998|151
Early-Onset Preeclampsia Is Associated With Gut Microbial Alterations in Antepartum and Postpartum Women
|Frontiers in Cellular and Infection Microbiology|2019|150
Direct Synthesis of Unprotected 4-Aryl Phenylalanines via the Suzuki Reaction under Microwave Irradiation
|Organic Letters|2002|83
An Early Fecal Microbiota Transfer Improves the Intestinal Conditions on Microflora and Immunoglobulin and Antimicrobial Peptides in Piglets
|Journal of Agricultural and Food Chemistry|2020|65
Potent quinoxaline-Based inhibitors of PDGF receptor tyrosine kinase activity. Part 1: SAR Exploration and Effective Bioisosteric Replacement of a phenyl substituent
|Bioorganic & Medicinal Chemistry Letters|2003|44